Why Is Eli Lilly and Company (LLY) Among the Best Large-Cap Value Stocks to Buy in 2025?
We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article, we are going to take a ...
The FDA is about to make weight-loss drugs a lot harder to get
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Psoriasis Drugs Market To Reach USD 52.34 Billion By 2033, Growing At A 11.50% CAGR
psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...
Former chemical workers call out Goodyear to clear the Niagara Falls air
Residents living near the Goodyear plant in Niagara Falls are calling for action after a report from the 7 News I-Team ...
A Pittsburgh guide for winter activities with 'Discover the Burgh'
Jeremy and Angie, from "Discover the Burgh," stopped by to talk with us about some indoor and outdoor activities in ...
wdef.com6d
How food brands and drugmakers are responding to FDA’s ban of food dye Red 3
Companies say they are working to update their products to comply with the Food and Drug Administration's decision ...
cweb7d
Eli Lilly: Dominating the Diabesity Market with Long-Term Growth Potential
BofA Securities analysts reaffirmed a Buy rating for Eli Lilly (NYSE:LLY) with a price target on the stock of $997. The company stands out as a premier opportunity within the large-cap biopharma ...
Le Lézard8d
FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
Omvoh is the first biologic treatment in more than 15 years to have disclosed two-year Phase 3 efficacy data in Crohn's disease at the time of approval. 2 "The burden of Crohn's disease on patients' ...
Osteoporosis screening guidelines updated: Do you need a bone scan?
“The term osteoporosis screening refers to use of bone density, x-ray studies or other tools to identify persons at an increased risk of fractures or bone breaks,” Dr. Thomas Weber, an endocrinologist ...